The Discounted Cash Flow (DCF) valuation of Devyser Diagnostics AB (DVYSR.ST) is (54.03) SEK. With the latest stock price at 88.90 SEK, the upside of Devyser Diagnostics AB based on DCF is -160.8%.
Based on the latest price of 88.90 SEK and our DCF valuation, Devyser Diagnostics AB (DVYSR.ST) is a sell. selling DVYSR.ST stocks now will result in a potential gain of 160.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.4% - 8.7% | 7.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (411.12) - (28.84) | (54.03) |
| Upside | -562.5% - -132.4% | -160.8% |